New therapeutic option now available for select treatment resistant lung cancer patients.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Clinicians, Researchers And Industry Collaborate With The 100,000 Genomes Project
ACMG respond to CMS statement with a new position on Clinical Utility of Genetic and Genomic Services.
Cincinnati Children’s Hospital Medical Center receives multi million dollar award to support newborn screening data resource.
Magazine Issue 2 goes out, and a trip out to Source Bioscience.
New University of Michigan study adds to the growing body of evidence that patients welcome WGS.
Genome-scale study points to drivers of tumor evolution and metastasis, provides roadmap for future in vivo Cas9 screens
‘Professor Eric Lander is one of the leaders of the Human Genome Project, and a member of US President Barack Obama’s scientific advisory panel. In an exclusive interview to NDTV, he explains how mapping the human gene has brought science to the edge of major breakthrough in the fight against cancer.’
23andMe and FDA make significant progress in direct-to-consumer testing.
Tel Aviv University researcher identifies novel genetic mutations through DNA sequencing of afflicted child and family.
A new UK based project, seeks to improve understanding of blood cancer genomics for improved treatment.